Altium Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$935K Buy
1,938
+718
+59% +$355K 0.07% 167
2022
Q1
$599K Sell
1,220
-44
-3% -$20.1K 0.04% 233
2021
Q4
$586K Buy
1,264
+209
+20% +$87.9K 0.04% 218
2021
Q3
$393K Sell
1,055
-35
-3% -$13.3K 0.03% 268
2021
Q2
$416K Sell
1,090
-34
-3% -$13K 0.03% 257
2021
Q1
$403K Buy
1,124
+56
+5% +$18K 0.03% 257
2020
Q4
$343K Buy
1,068
+153
+17% +$47K 0.03% 262
2020
Q3
$246K Buy
915
+38
+4% +$10.2K 0.03% 294
2020
Q2
$231K Sell
877
-35
-4% -$9.34K 0.03% 293
2020
Q1
$207K Buy
912
+130
+17% +$35.4K 0.03% 293
2019
Q4
$236K Buy
+782
New +$215K 0.03% 245
2019
Q3
Sell
-729
Closed -$206K 290
2019
Q2
$206K Sell
729
-24
-3% -$6.56K 0.03% 259
2019
Q1
$216K Buy
+753
New +$218K 0.03% 252

Other funds holding ELV

Altium Wealth Management's ELV Position: Q2 2022 in Review

Altium Wealth Management increased its Elevance Health (ELV) stake by 59% in Q2 2022, buying an estimated $355K and bringing the position to 1,938 shares worth $935K. The position accounts for 0.07% of the portfolio, ranked #167.

Altium Wealth Management first reported a position in ELV in Q1 2019 and has held it in 13 quarters since. 1,439 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Altium Wealth Management held 1,938 shares of Elevance Health worth $935K as of Q2 2022.
  • Altium Wealth Management bought 718 Elevance Health shares in Q2 2022, an estimated $355K.
  • Elevance Health made up 0.07% of Altium Wealth Management's portfolio in Q2 2022, its #167 holding.
  • Altium Wealth Management first reported a position in Elevance Health in Q1 2019 and has held it in 13 quarters since.
  • 1,439 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.